Chemodrug delivery using integrin-targeted PLGA-Chitosan nanoparticle for lung cancer therapy
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chemodrug delivery using integrin-targeted PLGA-Chitosan nanoparticle for lung cancer therapy
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-11-01
DOI
10.1038/s41598-017-15012-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Paclitaxel-loaded star-shaped copolymer nanoparticles for enhanced malignant melanoma chemotherapy against multidrug resistance
- (2017) Yongsheng Su et al. Drug Design Development and Therapy
- Tumor targeting strategies for chitosan-based nanoparticles
- (2016) Xingzhen Zhang et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Micro-CT Imaging of RGD-Conjugated Gold Nanorods Targeting TumorIn Vivo
- (2016) Xiaochao Qu et al. Journal of Nanomaterials
- A Green Light-Triggerable RGD Peptide for Photocontrolled Targeted Drug Delivery: Synthesis and Photolysis Studies
- (2016) Albert Gandioso et al. JOURNAL OF ORGANIC CHEMISTRY
- Transarterial administration of integrin inhibitor loaded nanoparticles combined with transarterial chemoembolization for treating hepatocellular carcinoma in a rat model
- (2016) Jun Qian et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Distinct functions and regulation of epithelial progesterone receptor in the mouse cervix, vagina, and uterus
- (2016) Fabiola F. Mehta et al. Oncotarget
- Chitosan-coated PLGA nanoparticles of bevacizumab as novel drug delivery to target retina: optimization, characterization, and in vitro toxicity evaluation
- (2016) Jayamanti Pandit et al. Artificial Cells Nanomedicine and Biotechnology
- Folate receptor-targeted nanoparticle delivery of HuR-RNAi suppresses lung cancer cell proliferation and migration
- (2016) Ranganayaki Muralidharan et al. JOURNAL OF NANOBIOTECHNOLOGY
- Effect of process and formulation variables on the preparation of parenteral paclitaxel-loaded biodegradable polymeric nanoparticles: A co-surfactant study
- (2016) Navneet Sharma et al. Asian Journal of Pharmaceutical Sciences
- Implications of αvβ3Integrin Signaling in the Regulation of Ca2+Waves and Myogenic Tone in Cerebral ArteriesSignificance
- (2015) Rania E. Mufti et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Crucial role of the protein corona for the specific targeting of nanoparticles
- (2015) Morteza Mahmoudi et al. Nanomedicine
- Chitosan-coated poly(lactic-co-glycolic) acid nanoparticles as an efficient delivery system for Newcastle disease virus DNA vaccine
- (2014) Kai Zhao et al. International Journal of Nanomedicine
- Chitosan Coated Polylactic Acid Nanoparticle-Mediated Combinatorial Delivery of Cisplatin and siRNA/Plasmid DNA Chemosensitizes Cisplatin-Resistant Human Ovarian Cancer Cells
- (2014) Anish Babu et al. MOLECULAR PHARMACEUTICS
- Pathophysiology of Cisplatin-Induced Acute Kidney Injury
- (2014) Abdullah Ozkok et al. Biomed Research International
- RGD-conjugated solid lipid nanoparticles inhibit adhesion and invasion of αvβ3 integrin-overexpressing breast cancer cells
- (2014) Dan Shan et al. Drug Delivery and Translational Research
- Chitosan-Modified PLGA Nanoparticles with Versatile Surface for Improved Drug Delivery
- (2013) Yichao Wang et al. AAPS PHARMSCITECH
- Paclitaxel-PHBV nanoparticles and their toxicity to endometrial and primary ovarian cancer cells
- (2013) Cristian Vilos et al. BIOMATERIALS
- Determination of Drug Release Kinetics from Nanoparticles: Overcoming Pitfalls of the Dynamic Dialysis Method
- (2013) Sweta Modi et al. MOLECULAR PHARMACEUTICS
- Combination treatment with paclitaxel and doxorubicin inhibits growth of human esophageal squamous cancer cells by inactivation of Akt
- (2013) HWAN HEE LEE et al. ONCOLOGY REPORTS
- Targeted Drug Delivery Systems Mediated by a Novel Peptide in Breast Cancer Therapy and Imaging
- (2013) Ruei-Min Lu et al. PLoS One
- Tumor-Penetrating Peptides
- (2013) Tambet Teesalu et al. Frontiers in Oncology
- Chitosan-coated PLGA nanoparticles: A sustained drug release strategy for cell cultures
- (2012) Laura Chronopoulou et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- On PAR with PARP: cellular stress signaling through poly(ADP-ribose) and PARP-1
- (2012) X. Luo et al. GENES & DEVELOPMENT
- Positive Surface Charge Enhances Selective Cellular Uptake and Anticancer Efficacy of Selenium Nanoparticles
- (2012) Bo Yu et al. INORGANIC CHEMISTRY
- The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles
- (2012) Eleonore Fröhlich International Journal of Nanomedicine
- A Chemical Approach for Cell-Specific Targeting of Nanomaterials: Small-Molecule-Initiated Misfolding of Nanoparticle Corona Proteins
- (2012) Kanlaya Prapainop et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- RGD-Based Strategies To Target Alpha(v) Beta(3) Integrin in Cancer Therapy and Diagnosis
- (2012) Fabienne Danhier et al. MOLECULAR PHARMACEUTICS
- Effect of ligand density, receptor density, and nanoparticle size on cell targeting
- (2012) Drew R. Elias et al. Nanomedicine-Nanotechnology Biology and Medicine
- Combination Erlotinib-Cisplatin and Atg3-Mediated Autophagy in Erlotinib Resistant Lung Cancer
- (2012) Jasmine G. Lee et al. PLoS One
- Paclitaxel resistance is associated with switch from apoptotic to autophagic cell death in MCF-7 breast cancer cells
- (2012) G M A Ajabnoor et al. Cell Death & Disease
- Autophagy counteracts apoptosis in human multiple myeloma cells exposed to oridonin in vitro via regulating intracellular ROS and SIRT1
- (2011) Rong Zeng et al. ACTA PHARMACOLOGICA SINICA
- Cyclic RGD Functionalized Gold Nanoparticles for Tumor Targeting
- (2011) Daniela Arosio et al. BIOCONJUGATE CHEMISTRY
- pH-Sensitive PEGylated Liposomes Functionalized With a Fibronectin-Mimetic Peptide Show Enhanced Intracellular Delivery to Colon Cancer Cells
- (2011) Ashish Garg et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- The proliferation rate paradox in antimitotic chemotherapy
- (2011) Timothy J. Mitchison MOLECULAR BIOLOGY OF THE CELL
- Blood clearance and tissue distribution of PEGylated and non-PEGylated gold nanorods after intravenous administration in rats
- (2011) Daniëlle PK Lankveld et al. Nanomedicine
- Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
- (2011) Hirenkumar K. Makadia et al. Polymers
- Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect
- (2010) Changyou Zhan et al. JOURNAL OF CONTROLLED RELEASE
- Cytotoxicity of Paclitaxel Incorporated in PLGA Nanoparticles on Hypoxic Human Tumor Cells
- (2009) Cheng Jin et al. PHARMACEUTICAL RESEARCH
- Kinetics of H2AX phosphorylation after exposure to cisplatin
- (2008) Peggy L. Olive et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Integrin αvβ3-targeted cancer therapy
- (2008) Zhaofei Liu et al. DRUG DEVELOPMENT RESEARCH
- Targeting colon cancer cells using PEGylated liposomes modified with a fibronectin-mimetic peptide
- (2008) Ashish Garg et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Polymeric nanoparticles for siRNA delivery and gene silencing
- (2008) Yogesh Patil et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- A new double emulsion solvent diffusion technique for encapsulating hydrophilic molecules in PLGA nanoparticles
- (2008) Einat Cohen-Sela et al. JOURNAL OF CONTROLLED RELEASE
- Paclitaxel-loaded PEGylated PLGA-based nanoparticles: In vitro and in vivo evaluation
- (2008) Fabienne Danhier et al. JOURNAL OF CONTROLLED RELEASE
- PR_b-Targeted PEGylated Liposomes for Prostate Cancer Therapy
- (2008) Döne Demirgöz et al. LANGMUIR
- PLGA, chitosan or chitosan-coated PLGA microparticles for alveolar delivery?
- (2007) Maria-Letizia Manca et al. COLLOIDS AND SURFACES B-BIOINTERFACES
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started